FDA report reaffirms safety profile and effectiveness of Bayer's Xarelto ® in routine clinical practice
A report from the U.S. Food and Drug Administration (FDA) published in Pharmacoepidemiology & Drug Safety confirms the safety profile and effectiveness of Xarelto® (rivaroxaban) in people with atrial fibrillation (AF). The study is based on electronic healthcare data within the Mini-Sentinel safety programme in the US, reporting data on a large real-world population of over 115,000 people prescribed rivaroxaban or warfarin. (Source: World Pharma News)
Source: World Pharma News - January 16, 2018 Category: Pharmaceuticals Tags: Featured Bayer Business and Industry Source Type: news
Apixaban cost effective versus warfarin for stroke prevention
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - December 1, 2017 Category: Drugs & Pharmacology Source Type: news
Mayo Clinic Q and A: Understanding and treating fibroelastomas
DEAR MAYO CLINIC:?I am an 83-year-old woman on warfarin because of atrial fibrillation, and I recently was diagnosed with a fibroelastoma.?Could you?give me a little information?on what this is, including the treatment and prognosis? ANSWER: Fibroelastomas are formally known as papillary fibroelastomas, or PFEs, and are sometimes called cardiac papillomas. These small, noncancerous tumors develop [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - November 28, 2017 Category: Databases & Libraries Source Type: news
Two new, large scale real-world analyses show fewer major bleeds and strokes with Pradaxa ® than with warfarin
(Source: Boehringer Ingelheim Corporate News)
Source: Boehringer Ingelheim Corporate News - November 27, 2017 Category: Research Source Type: news
ESC Congress 2014 Hot Line Session: Favourable effect of Pradaxa ® on kidney function over time compared to warfarin
(Source: Boehringer Ingelheim Corporate News)
Source: Boehringer Ingelheim Corporate News - November 27, 2017 Category: Research Source Type: news
Treatment with Pradaxa ® associated with better patient outcomes after a major bleeding event compared to warfarin
(Source: Boehringer Ingelheim Corporate News)
Source: Boehringer Ingelheim Corporate News - November 27, 2017 Category: Research Source Type: news
Better outcome in case of major bleed for patients taking the anticoagulant Pradaxa ® compared to warfarin
(Source: Boehringer Ingelheim Corporate News)
Source: Boehringer Ingelheim Corporate News - November 27, 2017 Category: Research Source Type: news
Pradaxa ® (dabigatran etexilate) 150mg bid continues to be the only oral anticoagulant which showed superior ischaemic stroke reduction vs. warfarin in its pivotal study RE-LY® – Results of the ENGAGE AF-TIMI 48 trial published for edoxaban vs. warfarin do
(Source: Boehringer Ingelheim Corporate News)
Source: Boehringer Ingelheim Corporate News - November 27, 2017 Category: Research Source Type: news
NOACs Show Lower Risk of Adverse Renal Outcomes in A - Fib
Compared with warfarin, dabigatran and rivaroxaban linked to lower risk of adverse renal outcomes (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - November 21, 2017 Category: Cancer & Oncology Tags: Cardiology, Endocrinology, Family Medicine, Geriatrics, Gynecology, Internal Medicine, Critical Care, Emergency Medicine, Nephrology, Neurology, Nursing, Oncology, Pathology, Pharmacy, Pulmonology, Journal, Source Type: news
Clinical outcomes and history of fall in patients with atrial fibrillation treated with oral anticoagulation: insights from the ARISTOTLE Trial - Rao MP, Vinereanu D, Wojdyla DM, Alexander JH, Atar D, Hylek EM, Hanna M, Wallentin L, Lopes RD, Gersh BJ, Granger CB.
PURPOSE: We assessed outcomes among anticoagulated patients with atrial fibrillation (AF) and a history of falling, and whether the benefits of apixaban versus warfarin are consistent in this population. METHODS: Of the 18,201 patients in ARISTOTLE... (Source: SafetyLit)
Source: SafetyLit - November 13, 2017 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news
Warfarin Linked to Lower Cancer Risk Warfarin Linked to Lower Cancer Risk
A large observational study finds a lower incidence of cancer in warfarin users, which could have important implications for the selection of medications for patients needing anticoagulation, researchers say.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 10, 2017 Category: Consumer Health News Tags: Cardiology News Source Type: news
Warfarin Use Tied to Lower Cancer Risk
Use of warfarin is associated with reduced incidence of cancer among older adults, according to an observational study in JAMA Internal Medicine. Using Norwegian registries... (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - November 9, 2017 Category: Primary Care Source Type: news
Speed makes a difference when using clot-stabilising drug in severe bleeding
Immediate treatment with clot-stabilising drug can reduce risk of death due to blood loss by 70% Related items fromOnMedica Heavy menstrual bleeding Bleeding risk with long-term aspirin increases substantially with age Direct oral anticoagulants as safe as warfarin after VTE Include pregnant women in studies, urge researchers (Source: OnMedica Latest News)
Source: OnMedica Latest News - November 8, 2017 Category: UK Health Source Type: news
Warfarin Use Tied to Lower Cancer Risk (FREE)
By Kelly Young
Edited by David G. Fairchild, MD, MPH, and Jaye Elizabeth Hefner, MD
Use of warfarin is associated with reduced incidence of cancer among older adults, according to an observational study in JAMA Internal … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - November 7, 2017 Category: Primary Care Source Type: news
Lower risk of several cancers in people taking warfarin
Lower cancer incidence across a broad range of malignant neoplasms in people older than 50 (Source: OnMedica Latest News)
Source: OnMedica Latest News - November 7, 2017 Category: UK Health Source Type: news
